Bayer's chloroquine donation to U.S. raises concern about FDA standards in pandemic

On Mar 21, two days after President Trump first touted chloroquine drugs as a "gamechanger" in the fight against COVID-19, administration officials privately described what they felt was a "win" in the President's efforts to build an emergency stockpile of the drugs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3bj3siH
via IFTTT